Evidence map›Paper›PMID 40584912›Full record

ArticleBioImpacts : BI2025

Critical-size bone defect repair with three types of nano-hydroxyapatite scaffolds: An

Mohammad Yousefi, Nicola Maffulli, Marjan Bahraminasab, Samaneh Arab, Akram Alizadeh, Ali Ghanbari, Athar Talebi, Muhammad Mehdi Jafari Sorkhdehi

Abstract read
In one paragraph

Article in BioImpacts : BI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mohammad YousefiStudent Research Committee, Semnan University of Medical Sciences, Semnan, Iran.ORCID https://orcid.org/0000-0003-0173-0817
Nicola MaffulliDepartment of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, SA, Italy.
Marjan BahraminasabNervous System Stem Cells Research Center, Semnan University of Medical Sciences, Semnan, Iran.ORCID https://orcid.org/0000-0003-3012-9799
Samaneh ArabDepartment of Tissue Engineering and Applied Cell Sciences, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.ORCID https://orcid.org/0000-0003-1831-3729
Akram AlizadehNervous System Stem Cells Research Center, Semnan University of Medical Sciences, Semnan, Iran.
Ali GhanbariResearch Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran.
Athar TalebiDepartment of Tissue Engineering and Applied Cell Sciences, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
Muhammad Mehdi Jafari SorkhdehiStudent Research Committee, Semnan University of Medical Sciences, Semnan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Hydroxyapatite (HA), the main mineral component of bone, can be synthesized and utilized in the bone lesion treatments because of its high bioactivity and osteoconductive property. HA extraction from fish bones has received special attention given its low cost and easier extraction protocol compared to other sources. The present study compared the biocompatibility and bone repair of commercial nano hydroxyapatite (nHA) powder with that extracted from carp and human bones Methods: First, nHA powders were prepared, and their physical and structural properties were studied using XRD, FTIR, FE-SEM and EDS analyses. Next, the powders were used to make porous scaffolds for which the physicochemical, structural, mechanical and biological properties were evaluated. The Results: The morphological and phase analyses showed the successful fabrication of porous nHA scaffolds with 60.68%, 61.38, and 63.27% for carp, human and commercial nHA scaffolds, respectively. The scaffolds showed different biodegradability behavior where the human nHA scaffolds degrade more rapidly. The results of mechanical tests indicated that the scaffolds made up of human extracted nHA powder had the lowest strength and stiffness (3.13 and 37.37 KPa, respectively). The strength and stiffness of the scaffolds fabricated by carp extracted and commercial nHA were 17.14 and 19.01 Kpa, and 251.79 and 140.49 Kpa, respectively. The MTT test results showed that the greatest cell viability rate was in the carp nHA scaffolds after 10 days (146.08%). Moreover, the AR staining indicated the formation of mineralized nodules caused by the scaffolds in all groups. However, the mineralization seemed to be superior in human, and carp extracted groups. Furthermore, Conclusion: The carp extracted nHA scaffolds perform comparable to human extracted nHA, and may be used for clinical applications.

Indexed as

BiocompatibilityBone defectCarpIn vivoNano hydroxyapatiteRat skull

Identifiers

PMID40584912
PMCPMC12204782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.